arrow
I

Isabel Rodríguez-Góncer

instituto de investigacion sanitaria hospital 12 de octubre imas12
H指数:12
被引数:501

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Infectious Complications in Living Donation Versus Donation After Brain Death Kidney Transplantation

活体捐赠与脑死亡后捐赠肾脏移植中的感染并发症

2026-09-250
PRE
Solid Organ Transplant Recipients With Clostridioides difficile Infection Had Lower Fecal Calprotectin and Lactoferrin Levels Compared to Immunocompetent Patients: Implications for Biomarker Interpretation

与免疫健全患者相比,固體器官移植受者中<em>Clostridioides difficile</em>感染者的粪便钙卫蛋白和乳铁蛋白水平较低:对生物标志物解释的启示

2026-09-230
PRE
Epidemiology and Risk Factors for Infection in Multiple Myeloma Patients Treated With Bispecific Antibodies

多发性骨髓瘤患者接受双特异性抗体治疗后感染流行病学及危险因素

2026-08-120
OAAI
Rezafungin for Salvage or Consolidation Therapy of Invasive Fungal Disease: Experience in Real-World Clinical Practice

瑞扎芬格用于侵袭性真菌病的挽救或巩固治疗:真实世界临床实践经验

Mycoses
IF3.1
2026-02-200
OAAI
False-positive results of the turbidimetric β-D-glucan assay in patients with bacteremia

血培养阳性患者浊度法β-D-葡聚糖检测的假阳性结果

2025-11-010
PRE
Management of multidrug-resistant gram-negative bacilli infections in adult solid organ transplant recipients: GESITRA-IC/SEIMC, CIBERINFEC, and SET recommendations update.

多药耐药革兰阴性杆菌感染在成年实体器官移植受者中的管理:GESITRA-IC/SEIMC、CIBERINFEC和SET指南更新。

2025-07-010
PRE
Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update

成人实体器官移植患者的巨细胞病毒管理: gesitra-ic-seimc,ciberclim和SET建议更新

2024-12-017
OAAI
Executive summary of the consensus statement of the group for the study of infection in transplantation and other immunocompromised host (GESITRA-IC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the treatment of SARS-CoV-2 infection in solid organ transplant recipients
2023-12-016
PRE
Production of OXA-48 carbapenemase acts as an independent risk factor for poor outcome in Klebsiella pneumoniae infection

OXA-48碳青霉烯酶的产生是肺炎克雷伯菌感染预后不良的独立危险因素

2023-10-270
PRE
Dynamics and Clinical Significance of Cytomegalovirus-Specific Neutralizing Antibodies in Kidney Transplant Recipients Treated with T-Cell-Depleting Agents
2023-09-222
PRE